Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute...(bipolardisorder are able to make informe...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Date:6/9/2008
bipolar disorder are able to make informed decisions regarding their treatment in an acute agitated state and would prefer a treatment option that is rapid-acting and noninvasive.
Alexza believes there is a significant unmet medical need for an alternative treatment option for acute agitation that will provide a faster onset of effect, that is non-invasive and safe for medical personnel to administer, and will facilitate trust between the patient and the treating clinician.
About AZ-004 (Staccato loxapine)
AZ-004 is the combination of Alexza's proprietary Staccato system with loxapine, a drug belonging to the class of compounds known generally as atypical antipsychotics. The Staccato system technology used in AZ-004 is a hand-held, chemically-heated, single dose inhaler designed to generate and deliver excipient-free loxapine aerosol for deep lung delivery that results in IV-like pharmacokinetics. Alexza has now completed four clinical trials with AZ-004, this 344 patient Phase 3 study, a 50 subject Phase 1 study, a 129 patient Phase 2 study, and a 32 patient multiple-dose tolerability and PK study in schizophrenic patients.
The Company believes that the unique delivery of loxapine via the
Staccato system will provide rapid onset of drug effect, as measured by a
reduction in the signs and symptoms of acute agitation. In March 2007,
Alexza announced positive initial results from a multi-center, randomized,
double-blind, placebo-controlled Phase 2 clinical trial in 129 patients in
an in-patient clinical setting. The 10 mg dose of AZ-004 met the primary
endpoint of the clinical trial, which was a statistically significant
reduction in the measure of agitation from baseline to the 2-hour post-dose
time point, as compared to placebo. The 10 mg dose of AZ-004 also exhibited
a rapid onset of effect, with a statistically significant improvement in
the PEC scores at 20 minutes post-dose, as compared to placebo, and
sustained effectiveness through
'/>"/>
| SOURCE Alexza Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
(Date:12/16/2009)... -- Siemens Healthcare today announced a ... to help healthcare providers pursue ... within the HITECH provision of the American ... Featuring zero-percent interest terms for qualified customers, ... payments associated with their technology investment while ...
(Date:12/16/2009)... Virginia, December 16 Biovista Inc.,today announced ... Presentation Award,in Healthcare, at the 2009 New England ... The award, which recognizes cutting edge private companies,driving ... who competed with,over 50 other privately held companies ... Technology, Life Sciences and Clean-tech sectors. , ...
(Date:12/16/2009)... Avantium announced the,appointment of Gunnar Staaf as ... Staaf previously worked at Serentis Ltd, Astellas ... a range of commercial and executive,positions. The ... plan to,spin-out its pharmaceutical business. The company ... on its offering of proprietary,crystallization services and ...
Breaking Medicine Technology:Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4Biovista Inc. Named Top Innovator in Life Sciences 2Avantium Appoints Gunnar Staaf as CEO Pharma 2Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500 28TM 29 5614 1Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500 28TM 29 5614 2Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500 28TM 29 5614 3Health information exchange conquers new frontier 3A Emergency medical services 59834 1Health information exchange conquers new frontier 3A Emergency medical services 59834 2Just published 3A Doctor of the Heart 3A My Life in Medicine by Isadore Rosenfeld M D 10438 1Just published 3A Doctor of the Heart 3A My Life in Medicine by Isadore Rosenfeld M D 10438 2... --,Advanced Magnetics today announced that data from three ... as an,intravenous iron replacement therapeutic will be presented ... Meetings,taking place April 10th through 14th in Orlando, ... be presented on,Wednesday, April 11, 2007 at approximately ...
... 2007 - Advanced Cell,Technology, Inc.'s (OTCBB: ACTC) ability ... Scientific American's March 2007 issue as the,lead story ... of the article,which notes Advanced Cell's ability to ... pigment epithelial (RPE),tissue," is timely as it comes ...
Other Medicine Technology:Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 2Advanced Cell Technology's Ability to Rescue Vision in Blind Rats,Noted in Scientific American 3(Date:12/17/2009)... Primary Children’s Hospital from nearby hot tub company helps raise ... , ... Salt Lake City, UT (PRWEB) ... announce the donation of a Bullfrog Spa to aid in ... Lake City, Utah. Primary Children’s Medical Center, serving child patients ...
(Date:12/16/2009)... Benefit of Children with Autism and Other Special Needs, ... Zachary Levi Join Ben Stiller to Ring in the ... -- At its 13th annual Teddy Bear Ball, The ... & CEO Brian Goldner received the ... far-reaching philanthropic leadership and commitment to children,s causes; ...
(Date:12/16/2009)... Losing has never felt so good for "The Biggest ... lifestyle means continuing to make smart choices everyday to ... one healthy choice that is an important part of ... take. Every glass of milk has nine essential nutrients ... normal blood pressure, and calcium and vitamin D for ...
(Date:12/16/2009)... 16 HealthSciences Institute will sponsor ... professionals, teams and organizations who serve individuals ... diseases in employer, health plan, medical home ... will offer free, noncommercial webinars on topics, ... prevention, management and care improvement. Each webinar ...
(Date:12/16/2009)... health and environmental concerns about the emerging nanotechnology industry, ... behavior of nanoparticles in municipal sewage treatment plants ... published in ACS, journal Environmental Science & Technology ... Ecology and Hydrology and colleagues note that experts predict ... less than 1/1000th the width of a human hair ...
Breaking Medicine News(10 mins):Health News:Bullfrog Spas Helps Critically Ill Children 2Health News:Bullfrog Spas Helps Critically Ill Children 3Health News:Bullfrog Spas Helps Critically Ill Children 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Behavior modification could ease concerns about nanoparticles 2[0] Bullfrog Spas Helps Critically Ill Children [1] The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests[1] 'The Biggest Loser' Champ Lives Well With Milk[1] New Learning Collaborative to Prepare Clinicians for Better Chronic Care[0] Behavior modification could ease concerns about nanoparticles
... Bain ... Capital and TPG, RESEARCH ... formation of a new investor,partnership to support the company,s continued growth ... the management team.,Gillings and global private investment firms Bain Capital and ...
... Highlights include generic drug use, diagnostic imaging, ... to improve the quality and efficiency of care ... support for diagnostic,imaging which HealthPartners introduced in February, ... program provides physicians the latest,guidelines from the American ...
... When men leave the,hospital after prostate surgery, they ... than not, a spouse is called on to be ... confidence,necessary to provide all the care needed. In many ... the patient., Laurel Northouse, Ph.D. from the University ...
... 3 to 4 per day after service was added to ... Simply adding a salad bar to the school lunch room ... U.S. researchers say. , The University of California, Los Angeles, ... three L.A. area schools. The children were interviewed before and ...
... Researchers from the Universities of Warwick, Edinburgh, Dundee and ... new light-activated platinum-based compound that is up to 80 ... which can use light activation to kill cancer ... , The platinum-based compound known as trans, trans, trans- ...
... Systems Inc.,(Amex: PLC ) announced today that it ... clearing the way for the Company to begin,its initial ... Company,expects to initiate a limited launch of RenalGuard(TM) in ... who recognize the benefits of,utilizing the unique fluid balancing ...
Other Medicine News:Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 2Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 3Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 4Health News:HealthPartners Reports 2007 Most Cost Effective Programs Reduce Expenses by $74 Million 2Health News:Helping Couples Fight Prostate Cancer, This Week on Your Cancer Today(TM) 2Health News:School Salad Bar Boosts Kids' Fruit, Veggie Intake 2Health News:Light powered platinum more targeted and 80 times more powerful than similar cancer treatments 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 3Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 4Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3iHealthPartners Reports 2007 Most Cost Effective Programs Reduce Expenses by $74 MillionHelping Couples Fight Prostate Cancer, This Week on Your Cancer Today(TM)School Salad Bar Boosts Kids' Fruit, Veggie IntakeLight powered platinum more targeted and 80 times more powerful than similar cancer treatmentsPLC Systems Receives CE Mark Approval for RenalGuard(TM)
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
The ICP-Monitor for intraventricular, intraparenchymal and epidural measurement of intracranial pressure and for measuring cerebral perfusion pressure and compliance....
... ICP Monitoring System provides ... intracranial pressure at the ... levels. The information is ... through a hydrostatic column ...
Penfield Dissector #3...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |